Phenylglyoxylic acid

Phenylglyoxylic acid (CAS No.: 611-73-4) is an aromatic alpha keto carboxylic acid and endogenous small molecule metabolite that is primarily studied as a biochemical marker of ethylbenzene and styrene biotransformation, making it relevant to exposure biology, toxicology, and metabolism focused life sciences research, and in biomedical discovery workflows it is commonly categorized as a metabolite standard and synthesis building block for research intermediates rather than a direct bioactive lead, with current evidence indicating that its principal biological significance arises from formation through xenobiotic oxidation pathways and downstream handling by detoxification and organic acid metabolic processes, while direct high affinity protein target engagement and pathway specific pharmacology remain insufficiently defined in the literature; accordingly, no robust and universally accepted IC50, EC50, or MIC activity benchmarks are established for canonical receptor or enzyme inhibition, and where exploratory assays are performed activity should be interpreted as context dependent and generally discussed in qualitative terms rather than as validated potency endpoints, with typical research applications including analytical method development, metabolism and biomonitoring studies, comparative profiling in cell based toxicity systems, incorporation into exposure related animal model investigations, and use as a precursor like scaffold in medicinal chemistry route design, and the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives.